Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of AZD5305 Alone and with Other Cancer Drugs for Patients with Advanced Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Czechia Hungary Italy Poland Spain
  • Study of Dazostinag and Pembrolizumab for Adults with Advanced or Metastatic Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Austria Belgium France Poland
  • Study of PRS-344/S095012 and obinutuzumab combination for patients with solid tumors – First human trial to evaluate safety and effectiveness

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Spain
  • Study of ASP1570 Alone or with Pembrolizumab for Adults with Advanced Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Spain
  • Study of Lenvatinib for Children and Young Adults with Relapsed or Refractory Solid Tumors, Including High Grade Glioma and Rhabdomyosarcoma

    Not recruiting

    2 1 1
    Investigated Drugs:
    Czechia France Italy Spain
  • Study of Entrectinib for Patients with Advanced or Metastatic Solid Tumors with Specific Gene Changes

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    France Germany Italy The Netherlands Poland Spain
  • Study on CTL-002 and Nivolumab for Patients with Advanced-Stage, Relapsed/Refractory Solid Tumors

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Germany Spain
  • Study on the Safety and Effects of [177Lu]-NeoB in Patients with Advanced Solid Tumors Overexpressing GRPR

    Not recruiting

    2 1 1
    Investigated Diseases:
    Austria France The Netherlands Spain
  • Study on Atezolizumab and Drug Combinations for Advanced Malignancies in Patients from Previous Atezolizumab Trials

    Not recruiting

    3 1 1 1
    Belgium Czechia France Germany Greece Hungary +5
  • Study on the Effectiveness of Inavolisib, Atezolizumab, and Entrectinib in Patients with Advanced or Metastatic Solid Tumors

    Not recruiting

    2 1 1 1
    Belgium Denmark France Germany Italy Poland +2